Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Oxygen 1件: Oxygen3件: Medical air; Nitrogen; Oxygen; --20件: 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330
2 Glucose 1件: D-glucose2件: D-glucose; Glucose; --3件: 49, 86, 88
3 L-Cysteine 1件: Cysteine2件: Cysteine; Cysteine hydrochloride; --11件: 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310
4 Thrombin 1件: Thrombin1件: Thrombin; --2件: 86, 88
5 Iodine 1件: Iodine2件: Iodine; Iodo; --3件: 28, 46, 88
6 Cefixime 1件: Atorvastatin3件: Atorvastatin; Atorvastatin Calcium; Lipitor; --18件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299
7 Warfarin sodium 1件: Warfarin2件: Warfarin; Warfarin Sodium; 2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬13件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97
8 Atorvastatin calcium anhydorous 1件: Atorvastatin3件: Atorvastatin; Atorvastatin Calcium; Lipitor; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬18件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299
9 Bosentan 1件: Bosentan2件: Bosentan; Tracleer; 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
10 Warfarin potassium 1件: Warfarin2件: Warfarin; Warfarin Sodium; 2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬13件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97
11 Imatinib mesylate 1件: Imatinib4件: Gleevec; GLIVEC; Imatinib; Imatinib Mesylate; 3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
12 Fludeoxyglucose F 18 1件: Fludeoxyglucose1件: FLUDEOXYGLUCOSE; --4件: 34, 84, 85, 88
13 Cysteine hydrochloride 1件: Cysteine2件: Cysteine; Cysteine hydrochloride; --11件: 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310
14 Ammonia solution, strong 1件: Ammonia1件: Ammonia; --3件: 86, 88, 296
15 Gadobenate dimeglumine 1件: Gadobenic acid2件: Gadobenate; MultiHance; --3件: 13, 86, 88
16 Treprostinil 1件: Treprostinil4件: Remodulin; Treprostinil; Treprostinilo; Tyvaso; 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬6件: 51, 84, 85, 86, 88, 210
17 Ambrisentan 1件: Ambrisentan3件: Ambrisentan; Letairis; VOLIBRIS; 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 51, 84, 85, 86, 88, 210, 211
18 Atorvastatin 1件: Atorvastatin3件: Atorvastatin; Atorvastatin calcium; Lipitor; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬18件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299
19 Bosentan 1件: Bosentan2件: Bosentan; Tracleer; 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
20 Gadobenic acid 1件: Gadobenic acid2件: Gadobenate; MultiHance; --3件: 13, 86, 88
21 Imatinib 1件: Imatinib4件: Gleevec; GLIVEC; Imatinib; Imatinib Mesylate; 3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
22 Potassium 1件: Potassium1件: Potassium; --12件: 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235
23 Warfarin 1件: Warfarin2件: Warfarin; Warfarin Sodium; 2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬13件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97
24 Riociguat 1件: Riociguat2件: Adempas; RIOCIGUAT; 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 51, 84, 86, 88, 225, 299
25 Edoxaban 1件: Edoxaban1件: Edoxaban; 1件: F10 💬1件: Complement and coagulation cascades 💬2件: 46, 88
26 Selexipag 1件: Selexipag2件: SELEXIPAG; Uptravi; 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬6件: 47, 51, 70, 84, 86, 88
27 Macitentan 1件: Macitentan2件: MACITENTAN; Opsumit; 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 51, 85, 86, 88, 210